메뉴 건너뛰기




Volumn 104, Issue 5, 2010, Pages 1009-1021

Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease

Author keywords

Classification; Collagen binding; Diagnosis; Von Willebrand disease; Von Willebrand factor; VWD; VWF

Indexed keywords

COLLAGEN; VON WILLEBRAND FACTOR;

EID: 78149491049     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-06-0360     Document Type: Article
Times cited : (58)

References (35)
  • 1
    • 33748802581 scopus 로고    scopus 로고
    • Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor
    • and the Working Party on von Willebrand Disease Classification
    • Sadler JE, Budde U, Eikenboom JCJ, et al. and the Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
    • (2006) J Thromb Haemost , vol.4 , pp. 2103-2114
    • Sadler, J.E.1    Budde, U.2    Eikenboom, J.C.J.3
  • 2
    • 33746602713 scopus 로고    scopus 로고
    • Laboratory identification of von Willebrand Disease: Technical and scientific perspectives
    • Favaloro EJ. Laboratory identification of von Willebrand Disease: Technical and scientific perspectives. Semin Thromb Hemost 2006; 32: 456-471.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 456-471
    • Favaloro, E.J.1
  • 3
    • 63149116476 scopus 로고    scopus 로고
    • Towards a new paradigm for the identification and functional characterisation of von Willebrand disease
    • Favaloro EJ. Towards a new paradigm for the identification and functional characterisation of von Willebrand disease. Semin Thromb Hemost 2009, 35: 60-75.
    • (2009) Semin Thromb Hemost , vol.35 , pp. 60-75
    • Favaloro, E.J.1
  • 4
    • 38549157588 scopus 로고    scopus 로고
    • An update on the von Willebrand factor collagen binding (VWF:CB) assay: 21 Years of age and beyond adolescence, but not yet a mature adult
    • Favaloro EJ. An update on the von Willebrand factor collagen binding (VWF:CB) assay: 21 years of age and beyond adolescence, but not yet a mature adult. Semin Thromb Hemost 2007; 33: 727-744.
    • (2007) Semin Thromb Hemost , vol.33 , pp. 727-744
    • Favaloro, E.J.1
  • 5
    • 51349134516 scopus 로고    scopus 로고
    • PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2
    • van Vliet HH, Kappers-Klunne MC, Leebeek FW, et al. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. Thromb Haemost 2008; 100: 462-468.
    • (2008) Thromb Haemost , vol.100 , pp. 462-468
    • Van Vliet, H.H.1    Kappers-Klunne, M.C.2    Leebeek, F.W.3
  • 6
    • 51349090488 scopus 로고    scopus 로고
    • A better approach to monitoring of therapy in von Willebrand disease?
    • Favaloro EJ. A better approach to monitoring of therapy in von Willebrand disease? Thromb Haemost 2008; 100: 371-373.
    • (2008) Thromb Haemost , vol.100 , pp. 371-373
    • Favaloro, E.J.1
  • 7
    • 63049090898 scopus 로고    scopus 로고
    • Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    • Favaloro EJ, Thom J, Patterson D, et al. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thromb Res 2009; 123: 862-868.
    • (2009) Thromb Res , vol.123 , pp. 862-868
    • Favaloro, E.J.1    Thom, J.2    Patterson, D.3
  • 8
    • 36949009872 scopus 로고    scopus 로고
    • Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - Collagen interaction in baboons
    • De Meyer SF, Staelens S, Badenhorst PN, et al. Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboons. Thromb Haemost 2007; 98: 1343-1349.
    • (2007) Thromb Haemost , vol.98 , pp. 1343-1349
    • De Meyer, S.F.1    Staelens, S.2    Badenhorst, P.N.3
  • 9
    • 34547862097 scopus 로고    scopus 로고
    • The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time
    • Wadanoli M, Sako D, Shaw GD, et al. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time. Thromb Haemost 2007; 98: 397-405.
    • (2007) Thromb Haemost , vol.98 , pp. 397-405
    • Wadanoli, M.1    Sako, D.2    Shaw, G.D.3
  • 10
    • 77953143516 scopus 로고    scopus 로고
    • Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome
    • Bongers TN, Emonts M, de Maat MP, et al. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome. Thromb Haemost 2010; 103: 1181-1187.
    • (2010) Thromb Haemost , vol.103 , pp. 1181-1187
    • Bongers, T.N.1    Emonts, M.2    De Maat, M.P.3
  • 11
    • 77952029378 scopus 로고    scopus 로고
    • Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart
    • Heilmann C, Geisen U, Beyersdorf F, et al. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Thromb Haemost 2010; 103: 962-967.
    • (2010) Thromb Haemost , vol.103 , pp. 962-967
    • Heilmann, C.1    Geisen, U.2    Beyersdorf, F.3
  • 12
    • 70350464416 scopus 로고    scopus 로고
    • Novel evaluation method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation
    • Udvardy ML, Szekeres-Csiki K, Hársfalvi J. Novel evaluation method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation. Thromb Haemost 2009; 102: 412-417.
    • (2009) Thromb Haemost , vol.102 , pp. 412-417
    • Udvardy, M.L.1    Szekeres-Csiki, K.2    Hársfalvi, J.3
  • 13
    • 78149472131 scopus 로고    scopus 로고
    • Genetic testing for the diagnosis of von Willebrand Disease: Benefits and limitations
    • Favaloro EJ, Krigstein M, Koutts J, et al. Genetic testing for the diagnosis of von Willebrand Disease: benefits and limitations. J Coag Disorders 2010; 2: 37-47.
    • (2010) J Coag Disorders , vol.2 , pp. 37-47
    • Favaloro, E.J.1    Krigstein, M.2    Koutts, J.3
  • 14
    • 51249102362 scopus 로고    scopus 로고
    • The molecular analysis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network
    • Keeney S, Bowen D, Cumming A, et al. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network. Haemophilia 2008; 14: 1099-1111.
    • (2008) Haemophilia , vol.14 , pp. 1099-1111
    • Keeney, S.1    Bowen, D.2    Cumming, A.3
  • 15
    • 33746616053 scopus 로고    scopus 로고
    • Reducing errors in identification of von Willebrand disease: The experience of the Royal college of Pathologists of Australasia Quality Assurance Program
    • on behalf of the RCPA QAP in Haematology
    • Favaloro EJ, Bonar R, Kershaw G, et al. (on behalf of the RCPA QAP in Haematology). Reducing errors in identification of von Willebrand disease: The experience of the Royal college of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2006; 32: 505-513.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 505-513
    • Favaloro, E.J.1    Bonar, R.2    Kershaw, G.3
  • 16
    • 33746644201 scopus 로고    scopus 로고
    • An external quality assessment program for von Willebrand factor laboratory analysis: An overview from the European concerted action on thrombosis and disabilities foundation
    • Meijer P, Haverkate F. An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation. Semin Thromb Hemost 2006; 32: 485-491.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 485-491
    • Meijer, P.1    Haverkate, F.2
  • 17
    • 33746615625 scopus 로고    scopus 로고
    • Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: Results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation
    • Kitchen S, Jennings I, Woods TA, et al. Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 2006; 32: 492-498.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 492-498
    • Kitchen, S.1    Jennings, I.2    Woods, T.A.3
  • 18
    • 33746612854 scopus 로고    scopus 로고
    • External peer review quality assurance testing in von Willebrand disease: The recent experience of the United States College of American Pathologists proficiency testing program
    • Hayes TE, Brandt JT, Chandler WL, et al. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program. Semin Thromb Hemost 2006; 32: 499-504.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 499-504
    • Hayes, T.E.1    Brandt, J.T.2    Chandler, W.L.3
  • 19
    • 63049088910 scopus 로고    scopus 로고
    • Lower limit of assay sensitivity: An under-recognised and significant problem in von Willebrand disease identification and classification
    • on behalf of the RCPA QAP Haemostasis Committee
    • Favaloro EJ, Bonar R, Marsden K (on behalf of the RCPA QAP Haemostasis Committee). Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification. Clin Lab Sci 2008; 21: 178-185.
    • (2008) Clin Lab Sci , vol.21 , pp. 178-185
    • Favaloro, E.J.1    Bonar, R.2    Marsden, K.3
  • 20
    • 34547890673 scopus 로고    scopus 로고
    • 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of Type 2B VWD
    • on behalf of the RCPA QAP in Haematology
    • Favaloro EJ, Bonar R, Meiring M, et al. (on behalf of the RCPA QAP in Haematology). 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of Type 2B VWD. Thromb Haemost 2007; 98: 346-358.
    • (2007) Thromb Haemost , vol.98 , pp. 346-358
    • Favaloro, E.J.1    Bonar, R.2    Meiring, M.3
  • 21
    • 54149117446 scopus 로고    scopus 로고
    • Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM- 1VWD) - A rebuttal
    • Favaloro EJ. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM- 1VWD) - a rebuttal. J Thromb Haemost 2008; 6: 1999-2001.
    • (2008) J Thromb Haemost , vol.6 , pp. 1999-2001
    • Favaloro, E.J.1
  • 22
    • 33845967766 scopus 로고    scopus 로고
    • Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
    • Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.
    • (2007) Blood , vol.109 , pp. 112-121
    • Goodeve, A.1    Eikenboom, J.2    Castaman, G.3
  • 23
    • 33644984651 scopus 로고    scopus 로고
    • Genetic linkage and association analysis in type 1 von Willebrand disease: Results from the Canadian type 1 VWD study
    • and Association of Hemophilia Clinic Directors of Canada
    • James PD, Paterson AD, Notley C, et al. and Association of Hemophilia Clinic Directors of Canada. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. J Thromb Haemost 2006; 4: 783-792.
    • (2006) J Thromb Haemost , vol.4 , pp. 783-792
    • James, P.D.1    Paterson, A.D.2    Notley, C.3
  • 25
    • 33751219230 scopus 로고    scopus 로고
    • An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease
    • the UK Haemophilia Centre Doctors' Organisation
    • Cumming A, Grundy P, Keeney S, et al.; the UK Haemophilia Centre Doctors' Organisation. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006; 96: 630-641.
    • (2006) Thromb Haemost , vol.96 , pp. 630-641
    • Cumming, A.1    Grundy, P.2    Keeney, S.3
  • 26
    • 0029084031 scopus 로고
    • Laboratory assessment of von Willebrand Factor: Use of different assays can influence the diagnosis of von Willebrand's Disease, depending on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms
    • Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand Factor: Use of different assays can influence the diagnosis of von Willebrand's Disease, depending on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 1995; 104: 264-271.
    • (1995) Am J Clin Pathol , vol.104 , pp. 264-271
    • Favaloro, E.J.1    Facey, D.2    Grispo, L.3
  • 27
    • 0033985083 scopus 로고    scopus 로고
    • Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD sub-types, depends on collagen source
    • Favaloro EJ. Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD sub-types, depends on collagen source. Thromb Haemost 2000; 83: 127-135.
    • (2000) Thromb Haemost , vol.83 , pp. 127-135
    • Favaloro, E.J.1
  • 28
    • 0034424843 scopus 로고    scopus 로고
    • Detection of von Willebrand Disorder (VWD) and identification of qualitative von Willebrand Factor (VWF) defects: Direct comparison of commercial ELISA-based 'VWF:Activity' options
    • Favaloro EJ. Detection of von Willebrand Disorder (VWD) and identification of qualitative von Willebrand Factor (VWF) defects: Direct comparison of commercial ELISA-based 'VWF:Activity' options. Am J Clin Pathol 2000; 114: 608-618.
    • (2000) Am J Clin Pathol , vol.114 , pp. 608-618
    • Favaloro, E.J.1
  • 29
    • 0027185973 scopus 로고
    • Von Willebrand's Disease: Laboratory investigation using an improved functional assay for von Willebrand Factor
    • Favaloro EJ, Grispo L, Dinale A, et al. von Willebrand's Disease: Laboratory investigation using an improved functional assay for von Willebrand Factor. Pathology 1993; 25: 152-158.
    • (1993) Pathology , vol.25 , pp. 152-158
    • Favaloro, E.J.1    Grispo, L.2    Dinale, A.3
  • 30
    • 13244252257 scopus 로고    scopus 로고
    • Standardization of factor VIII and von Willebrand factor in plasma: Calibration of the WHO 5th International Standard (02/150)
    • Hubbard AR, Heath AB. Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02/150). J Thromb Haemost 2004; 2: 1380-1384.
    • (2004) J Thromb Haemost , vol.2 , pp. 1380-1384
    • Hubbard, A.R.1    Heath, A.B.2
  • 31
    • 34548775941 scopus 로고    scopus 로고
    • Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease
    • Meiring M, Badenhorst PN, Kelderman M Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease. Clin Chem Lab Med 2007; 45: 1068-1072.
    • (2007) Clin Chem Lab Med , vol.45 , pp. 1068-1072
    • Meiring, M.1    Badenhorst, P.N.2    Kelderman, M.3
  • 32
    • 33747161013 scopus 로고    scopus 로고
    • Von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M
    • Baronciani L, Federici AB, Cozzi G, et al. von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M. J Thromb Haemost 2006; 4: 2088-2090.
    • (2006) J Thromb Haemost , vol.4 , pp. 2088-2090
    • Baronciani, L.1    Federici, A.B.2    Cozzi, G.3
  • 33
    • 0034537373 scopus 로고    scopus 로고
    • Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: Single center comparison of four different assays
    • Federici AB, Canciani MT, Forza I, et al. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: single center comparison of four different assays. Thromb Haemost 2000; 84: 1127-1128.
    • (2000) Thromb Haemost , vol.84 , pp. 1127-1128
    • Federici, A.B.1    Canciani, M.T.2    Forza, I.3
  • 34
    • 34147115746 scopus 로고    scopus 로고
    • Von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2
    • Veyradier A, Trossaert M, Lefrancois A, et al. von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2. J Thromb Haemost 2007; 5: 868-870.
    • (2007) J Thromb Haemost , vol.5 , pp. 868-870
    • Veyradier, A.1    Trossaert, M.2    Lefrancois, A.3
  • 35
    • 77956633476 scopus 로고    scopus 로고
    • A randomised pilot trial of the antivon Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
    • Jilma B, Paulinska P, Jilma-Stohlawetz P, et al. A randomised pilot trial of the antivon Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease. Thromb Haemost 2010; 104: 563-570.
    • (2010) Thromb Haemost , vol.104 , pp. 563-570
    • Jilma, B.1    Paulinska, P.2    Jilma-Stohlawetz, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.